Metastatic therapy is designed to treat cancer that has spread from the initial site, with the goal of suppressing disease progression, symptom relief, and enhancing patient quality of life. The session "Metastatic Therapy" emphasizes progress in systemic treatments, targeted therapy, and individualized approaches for the treatment of metastatic cancers.".
Therapies typically consist of chemotherapy, targeted therapy, immunotherapy, hormone therapy, and combination treatments. Precision medicine contributes significantly by designing therapies to the metastatic tumor's genetic and molecular signature, with the aim of eliciting maximal efficacy while causing minimal toxicity. Rapid progress in the areas of molecular profiling, biomarkers, and liquid biopsies enables early diagnosis of metastasis and informs treatment decisions.
The session also covers new therapeutic approaches, such as adaptive treatment plans, combination regimens, and emerging agents with the ability to break resistance and enhance survival rates. Multidisciplinary management, including supportive and palliative care, provides comprehensive management of metastatic disease.
Participants will become familiar with clinical practices, research breakthroughs, and evidence-based practices in the treatment of metastatic cancers. This session highlights ways in which personalized, targeted, and data-driven therapies in metastatic care can manage disease growth, improve quality of life, and offer patients better, more individualized treatments.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
